New drug combo for urinary symptoms from enlarged prostate
Part of Kidney & urinary clinical trials.
This trial tests whether a two-in-one pill can reduce the frequent and urgent need to pee caused by an enlarged prostate. It's for men who have had these symptoms for at least 3 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 40 or older.
- You have had an urgent need to pee (with or without leaking) and need to go 8 or more times in 24 hours for at least 3 months.
- You have not taken mirabegron or similar drugs for urinary symptoms in the last 30 days.
- You do not have a current urinary tract infection or a history of repeat infections.
- You have not had prostate or bladder surgery before, and you don't plan any surgeries during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new, once-daily tablet (H077) compared to the standard medicine silodosin for treating symptoms of an enlarged prostate. It aims to see if the new medicine works as well and is safe.
This trial tests a new drug, DTT106, for men who have both erectile dysfunction and an enlarged prostate (BPH). It is for men already taking dutasteride and tamsulosin and aims to see if the new treatment improves erections better.
This study monitors the safety of a medication called Vesomni in men being treated for urinary symptoms caused by an enlarged prostate in routine clinical care. Researchers will track how well the medication works and any side effects that occur.
This trial tests whether adding mirabegron (a pill to relax the bladder) after a Rezum procedure helps men with enlarged prostate symptoms. It aims to see if the combination improves urination more than Rezum alone.
This trial tests new treatment strategies for benign prostatic hyperplasia (BPH, an enlarged prostate) using a special MRI scan and a medication called finasteride. It aims to find better ways to manage symptoms and identify markers that predict response.
This study compares two treatments for men with moderate to severe urinary symptoms from an enlarged prostate. It looks at whether taking an alpha blocker with a plant-based supplement (Serenoa repens/saw palmetto) works better or has fewer side effects than taking an alpha blocker with a medicine that calms bladder spasms (antimuscarinic).
Hear when a new Benign Prostatic Hyperplasia with Lower Urinary Tract Symptoms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.